Acadia Healthcare (NASDAQ:ACHC) Given New $70.00 Price Target at Mizuho

Acadia Healthcare (NASDAQ:ACHC) had its price objective trimmed by Mizuho from $84.00 to $70.00 in a report published on Friday morning, Benzinga reports. The firm currently has a neutral rating on the stock.

Several other research analysts have also weighed in on ACHC. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a sell rating to a hold rating and set a $70.00 price objective for the company in a research report on Thursday, April 25th. Stephens upgraded Acadia Healthcare from an equal weight rating to an overweight rating and set a $92.00 price objective for the company in a research report on Friday, January 5th. TheStreet upgraded Acadia Healthcare from a c rating to a b- rating in a research note on Monday, March 4th. Bank of America decreased their price target on Acadia Healthcare from $105.00 to $90.00 and set a buy rating on the stock in a research note on Thursday. Finally, Barclays decreased their price target on Acadia Healthcare from $100.00 to $91.00 and set an overweight rating on the stock in a research note on Thursday. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of Moderate Buy and a consensus target price of $89.50.

Acadia Healthcare Price Performance

Shares of ACHC stock traded down $0.61 during trading hours on Friday, reaching $66.12. The company had a trading volume of 1,213,590 shares, compared to its average volume of 674,056. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.67 and a current ratio of 1.27. The stock has a fifty day moving average of $76.77 and a 200-day moving average of $77.52. The company has a market capitalization of $6.11 billion, a price-to-earnings ratio of -472.25, a PEG ratio of 1.97 and a beta of 1.31. Acadia Healthcare has a 12-month low of $64.74 and a 12-month high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, May 1st. The company reported $0.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.80 by $0.04. The business had revenue of $768.10 million during the quarter, compared to analyst estimates of $779.20 million. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The business’s revenue was up 9.1% compared to the same quarter last year. During the same period in the prior year, the business earned $0.75 earnings per share. On average, equities analysts anticipate that Acadia Healthcare will post 3.56 earnings per share for the current year.

Insider Activity at Acadia Healthcare

In related news, Director Wade D. Miquelon sold 2,203 shares of the stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total value of $188,114.17. Following the transaction, the director now owns 46,074 shares of the company’s stock, valued at $3,934,258.86. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 2.00% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Acadia Healthcare

Large investors have recently bought and sold shares of the business. Headlands Technologies LLC acquired a new stake in shares of Acadia Healthcare in the 3rd quarter valued at about $25,000. GAMMA Investing LLC acquired a new stake in shares of Acadia Healthcare in the fourth quarter valued at approximately $26,000. Mather Group LLC. purchased a new position in shares of Acadia Healthcare during the first quarter worth approximately $48,000. Fifth Third Bancorp grew its position in shares of Acadia Healthcare by 25.5% during the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock worth $52,000 after acquiring an additional 136 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale acquired a new position in shares of Acadia Healthcare in the 3rd quarter valued at $96,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.